You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 46122-0742


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 46122-0742

Drug Name NDC Price/Unit ($) Unit Date
GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET 46122-0742-68 0.09071 EACH 2025-01-22
GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET 46122-0742-68 0.08936 EACH 2024-12-18
GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET 46122-0742-68 0.08406 EACH 2024-11-20
GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET 46122-0742-68 0.08480 EACH 2024-10-23
GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET 46122-0742-68 0.08114 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 46122-0742

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 46122-0742

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a drug identified by the NDC 46122-0742, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product. It consists of a labeler code, a product code, and a package code, each assigned by different entities[1].

Drug Identification

The NDC 46122-0742 would be broken down as follows:

  • Labeler Code: The first segment, assigned by the FDA, identifies the firm that manufactures, repacks, relabels, or distributes the drug.
  • Product Code: The second segment, assigned by the firm, identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment, also assigned by the firm, identifies the package size and type.

Market Context

Life Sciences Industry Trends

The life sciences industry is undergoing significant transformations driven by digital advancements, scientific innovations, and regulatory changes. Pricing and access to drugs are among the most significant issues facing the industry, with nearly half of C-suite executives expecting these factors to significantly impact their strategies in 2025[3].

Drug Pricing Dynamics

High prescription drug prices continue to pose affordability challenges for patients, healthcare payers, and taxpayers. The Medicare Drug Price Negotiation Program, for example, has highlighted substantial price increases for many drugs between 2018 and 2023, with some drugs seeing increases of up to 55%[2].

Price Projections

Current Pricing Environment

For drugs like the one identified by NDC 46122-0742, the current pricing environment is influenced by several factors:

  • List Prices: Manufacturers report list prices (Wholesale Acquisition Cost or WAC) for drugs, which can vary significantly over time. For instance, nine out of ten drugs selected for Medicare negotiation saw list price increases ranging from 20% to 55% between 2018 and 2023[2].
  • Negotiated Prices: Programs like the Medicare Drug Price Negotiation Program are introducing negotiated prices that can significantly reduce the cost of drugs. For example, negotiated prices for the first ten drugs selected under this program resulted in discounts ranging from 38% to 79% compared to list prices[2].

Future Pricing Trends

Given the current trends, here are some potential future pricing trends for the drug NDC 46122-0742:

  • Regulatory Impact: Regulatory changes, such as those introduced by the Medicare Drug Price Negotiation Program, are likely to continue influencing drug prices. If this drug is selected for negotiation, its price could be significantly reduced.
  • Market Competition: The rise of generic drugs and biosimilars is expected to increase competition, potentially driving down prices. However, this would depend on whether the drug in question faces generic or biosimilar competition[3].

Market Analysis

Demand and Usage

To project prices accurately, understanding the demand and usage patterns of the drug is crucial. Factors such as the condition treated, patient population, and treatment duration play significant roles. For example, drugs treating common conditions like cardiovascular disease, diabetes, and cancer tend to have high demand and significant market impact[2].

Supply Chain and Distribution

The supply chain and distribution network also affect drug prices. The labeler, in this case, AmerisourceBergen Drug Corp (if similar to other products from the same labeler), would influence the pricing through their distribution strategies and costs[5].

Key Takeaways

  • NDC Breakdown: The NDC 46122-0742 identifies a specific drug product, including its labeler, product, and package details.
  • Pricing Dynamics: Drug prices are influenced by list prices, negotiated prices, and regulatory changes.
  • Market Trends: The life sciences industry is facing significant changes, including increased competition from generics and biosimilars, and a focus on digital transformation and innovation.
  • Regulatory Impact: Programs like the Medicare Drug Price Negotiation Program can significantly reduce drug prices through negotiated discounts.

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package details.

Q: How do regulatory changes affect drug prices? A: Regulatory changes, such as the Medicare Drug Price Negotiation Program, can introduce negotiated prices that significantly reduce the cost of drugs.

Q: What are the key factors influencing drug prices in the current market? A: Key factors include list prices, negotiated prices, regulatory changes, market competition from generics and biosimilars, and supply chain costs.

Q: How does the rise of generic drugs and biosimilars impact drug prices? A: The rise of generic drugs and biosimilars can increase competition, potentially driving down prices for branded drugs.

Q: What role does digital transformation play in the life sciences industry? A: Digital transformation is expected to boost operational efficiencies and drive breakthrough innovations, including personalized medicine and advanced therapeutic solutions.

Sources

  1. FDA: National Drug Code Database Background Information - FDA
  2. ASPE - HHS.gov: Medicare Drug Price Negotiation Program
  3. Deloitte Insights: 2025 life sciences outlook
  4. Roots Analysis: Drug Reconstitution Market Size, Share, Trends, Forecast (2035)
  5. FDA.report: NDC 46122-622 Oral Tablet Good Neighbor Antibacterial Plus ...

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.